Human cytomegalovirus (HCMV)-specific CD4+ and CD8+ T cells are both required for prevention of HCMV disease in seropositive solid-organ transplant recipients.

por Elisa Gabanti, Francesca Bruno, Daniele Lilleri, Chiara Fornara, Paola Zelini, Ilaria Cane, Clara Migotto, Eleonora Sarchi, Milena Furione, Giuseppe Gerna
Publicado 2014